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Abstract

SYSTEMATIC NURSING MANAGEMENT OF UNIVERSITY
STUDENTS WITH INFECTIOUS MONONUCLEOSIS
by
Lillian N. Yelton
Infectious Mononucleosis has been one of the most misdiagnosed
entities in medicine.

Its ability to mimic other diseases and the abun-

dance of misconceptions about it have long confused both diagnosis and
treatment.

Since there is still no specific drug to combat this disease.

patients with characteristic symptoms are treated symptomatically for the
period of extended convalescence.

This study was carried out to explore

the possible effects of systematic nursing management on Infectious Mono
nucleosis patients, in order to evaluate those things that significantly
influence the patient’s course of illness and recovery, in a university
outpatient health service.
The hypothesis formulated was:

a patient with Infectious Mono

nucleosis who receives systematic nursing management throughout the
course of his illness will, on the average, show a decreased length of
illness.
Random selection of twenty-four patients was made from those
students seeking, or who had sought, medical care for Infectious Mono
nucleosis at the Student Health Service of California State University,
Fullerton, California.
for this study.

No tools of measurement were developed especially

The researcher extracted necessary information from the

medical records, using a data sheet.
groups:

The sample was divided into two

twelve patients who were seeking treatment (the experimental

group), and twelve patients who had completed their treatment during the
previous academic year (the control group).

To assure uniformity of

nursing care, the researcher provided a manual for systematic nursing
management to be followed by the nurses who cared for the experimental
group of patients.
Although not statistically significant, the data from the study
showed the findings to be in the predicted direction of the hypothesis.
Interesting trends were seen indicating that some patients in the experi
mental group with Infectious Mononucleosis who received systematic nursing
management were, on the average, able to reduce the course of their clini
cal symptomatology to two weeks less than that of the control group, even
though their atypical lymphocyte level was higher at the time of their
voluntary admission to treatment.

The nurses caring for the experimental

group of patients through systematic nursing management increased their
Infectious Mononucleosis patient appointment load by 100 per cent, while
physicians treating the same group were able to reduce their Infectious
Mononucleosis patient appointment load by 31 per cent, thus freeing the
physicians to devote more time to other matters and patients who required
their special attention and clinical expertise.
Even though some limitations were placed on this study by its
small sample size and by the large variability manifested in the degree
of patients’ symptomatology, nursing implication from this study has been
significant in that the nurses caring for the experimental group of
patients, in their extended role with physician collaboration, were able

to render care comparable to that of the physicians who treated the con
trol group of patients.
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INTRODUCTION

Since there is still no specific drug to combat Infectious
Mononucleosis, patients with the symptoms of this disease are treated
symptomatically.

Though Infectious Mononucleosis has been in the medi

cal literature for half a century, it is one of the most misdiagnosed
entities in medicine.

Its ability to mimic other disease and the

abundance of misconceptions about it have long confused both diagnosis
and treatment.
The registered nurse is in a unique position to participate in
the surveillance and management of health care for university students
with Infectious Mononucleosis.

The nurse, an important member of the

health team in an ambulatory care setting, can work closely with her
patients to institute a systematic regimen of care in collaboration
with the physician.

Need for Study
There is little doubt about the importance of the nurse’s role
in the health improvement process of the patient with Infectious Mono
nucleosis.

However, to evaluate those things that significantly

influence the patient’s course of illness and to learn the relationship
between nursing management and patient recovery, analysis on an ongoing
basis in a variety of settings is needed.
The present growing concern for change in expanding the system
of health care has significant implications for nursing (Lysaught, 1970,
p. 81).

Today, physicians and nurses are collaborating to achieve more
1
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effective understanding of the complementary functions of medicine and
nursing, and to formulate practical applications (Ardine and others,
1973, pp. 655-657; Keller, 1973, p. 73).

The researcher has exper

ienced the development of new collaborative relationships between nurses
and physicians in the University Health Center since the nurses assumed
certain expanded roles.

Statistical data for the academic year of

1974-1975 for the Student Health Service of California State University,
Fullerton, California, showed 23,568 patient visits, 15,274 laboratory
procedures, and 1,508 radiological procedures.

The health service phy

sicians made 498 different medical diagnoses.

Each new patient seeking

medical care was screened by the registered nurse functioning in the
expanded role with physician collaboration (Wickett, 1975, p. 1).
acting in the new role can bring many benefits to patients.

Nurses

These bene-

fits were observed by the investigator in connection with certain health
problems such as Infectious Mononucleosis.
Information is limited, in medical literature, about the dura
tion of symptoms following acute infection and the nature of treatment.
The information available indicates disagreement as to treatment as well
as patient's symptomatology during the infection (Thompson and others.
1969, p. 453).

Therefore, the medical clinician must rely upon the

patient's clinical condition and treat the patient symptomatically
(Miller, L. and others, 1972, p. 55).
Problem
It is important for nurses to identify, document, and account
for professional intervention in order to evaluate those things that
significantly influence the patient's course of illness.
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The effectiveness of nursing intervention in the university
health services can be seen in many ways.
documented .

However, it has not been

In the case of Infectious Mononucleosis, due to the unique-

ness of the disease, and the fact that no specific drugs have been found
to combat the disease, adherence to a regimen over a period of time is
important since the management of the patient by the nurses plays an
important role in the recovery (Tagliacozzo, 1974, p. 596).
Purpose of Study
The purpose of this study is to investigate nursing interven
tions as they affect the patient’s course of illness and his rate of
recovery from Infectious Mononucleosis in a specific university health
service.
Hypothesis
A patient with Infectious Mononucleosis who receives systematic
nursing management throughout the course of his illness will, on the
average, show a decreased length of illness.
Definition of Terms

Systematic nursing management.

A plan which concerns the regis

tered nurse who is caring for the patients in an experimental group in
collaboration with physicians.

She will be the only nurse responsible

for providing systematic nursing care for this patient.

Under this

plan the nurse will, in cooperation with the patient, assess, plan.
implement and evaluate his health care.
a.

The plan includes:

Making the initial assessment, of the student’s status.

A
b.

Observing, listening to, and evaluating the student's needs.

Interpreting laboratory tests for progress according to defined pro
cedure.
c.

Channeling students to the physician for a diagnostic work-

up and treatment.
d.

Guiding the patient and taking the responsibility of teaching

and counseling him.
e.

Planning and coordinating nursing care with other health

care facilities.
f.

Assuring continuity and equality of health care for the

duration of his illness.

Length of illness.

Length of illness for this study was measured

by the number of days from the time of voluntary admission into treatment
until the time the level of atypical lymphocytes was 20 percent.
Atypical lymphocytes.
Infectious Mononucleosis.

Lymphocytosis is characteristic of

Many patients show lymphocytosis with 20-90

percent concentration of atypical lymphocytes.

White blood count

(W.B.C.), is usually elevated to about 15,000, although it may range
from 1,000 to 30,000.

Atypical lymphocytes are larger than normal,

more darkly stained, and frequently will show vacuolization of nuclei
and cytoplasm (Miller and others, 1972, p. 44; Lyght, 1966, p. 759;
Valentine, 1963, p. 1157).

Voluntary admission into treatment.

The day the patient enters

the student health center seeking help for his symptoms and the point
at which he is screened by the triage nurse.

5
Triage nurse.

The nurse who takes screening histories, physical

examinations, and orders appropriate laboratory tests
priorities in the patient’s needs.

to determine

This nurse also determines whether

or not the physician should see the patient immediately.

Infectious mononucleosis.

Infectious mononucleosis usually is

an acute, self-limiting disorder with characteristic symptoms of fever.
pharyngitis, lymphadenopathy, splenomegaly, fatigue, lymphocytosis with
many atypical lymphocytes and may show the production of the heterophile
antibodies (Barnes, 1974, p. 35).

The severity of this disorder is

determined by the virility of the innoculum (the virus), the host immune
mechanism, and the degree of physical prostration.

All these factors

must be considered together with laboratory findings and physical mani
festations in order to determine the patient’s degree of illness (Morton,
1975).

No specific therapy is available.

Secondary bacterial invasion

should be sought and treated with appropriate antimicrobial drugs.

Com

plete recovery is almost certain, but splenic rupture can result in rapid
death unless treated surgically immediately.

Neurologic complications

rarely occur (Valentine, 1963, p. 1159; Barnes, 1974, p. 35).
Assumptions
For purposes of this study, the following assumptions were made:
1.

The nurse has the knowledge and skills needed to render

systematic nursing management to the patient with Infectious Mononucleo
sis involving the physicians' collaboration.
2.

The university student/patient has the education and ability

to comprehend the course of his illness.

Thus, his participation in
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health management planning will be an important factor in carrying ou.t
the regimen.
3.

Physicians collaborate with nurses in patient care.

Limitations
1.

The patient’s personal coping mechanism and the support

system at home will vary.
2.

The nurse’s contact with her patient is limited because the

student health service is closed on week-ends and holidays.
3.

The patient's clinical response to the personality of the

nurse will vary.
4.

The selection of sample population for the experimental

group was restricted to the months of September through April.
5.

The investigator has no control over the degree of the

patient’s illness and how long he has been ill before he sought medical
help.
REVIEW OF LITERATURE
The first account of Infectious Mononucleosis is generally
credited to Pfeiffer who, in 1889, described an epidemic in children
which he termed "glandular fever."

Burns, in 1909, called attention

to an increase in mononuclear leukocytes in the blood.

Sprunt and

Evans first applied the name Infectious Mononucleosis to the disorder
in 1920, and directed attention to the abnormally high content of leukocytes in the blood.

The leukocytes were described in detail in 1923 by

Downey and McKinlay (Valentine, 1963, p. 1157).

Although Infectious

Mononucleosis has been in the medical literature for half a century.
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its etiology was not traced to Epstein-Barr Virus until late in 1968
by a husband and wife virologist team, Werner and Gertrude Henle.
However, it is a possibility that other nameless virus may have been
the cause of this disorder (Ginnis, 1968, p. 1; Hoagland, 1973, p. 98;
Miller, G.

1973, p. 229; Miller, L. , 1972, p. 44).

In December of

1975, evidence of Cytomegalovirus Mononucleosis in adults was reported
(Bonkowsky and others, 1975, p.1284; Rosenthal, 1975, p. 1300).
Infectious Mononucleosis occurs largely in the 15 to 25 age
group, with an estimated incidence of 50 cases per 100,000 in the general
population (Barnes, 1974, p. 34).
disorder is probably very rare.

The prevalence of recurrence of this
Dr. Rose, of University of Nebraska

Health Service, reported that after sixteen years’ experience with Infec
tious Mononucleosis representing thousands of cases, he has not en
countered a single recurrence.

Incidentally, Dr. Rose usually did two

or three years of follow-up study to substantiate his findings (Rose,
1972, p. 195).

The established facts are these:

Infectious Mononucle

osis is usually an acute, self-limiting illness of young adults and
children.

It is identified by certain clinical hematologic and sero-

logic manifestations.

Its characteristics are fever, malaise, pharyn

gitis, lymphadenopathy, lymphocytosis with atypical changes in the
mononuclear elements of the peripheral blood, and production of the
heterophile antibody (Barnes, 1974, p. 34; Dirckx, 1972, p. 45;
Valentine, 1963, p. 1157).

The symptomatic similarity of Mononucleosis

to other diseases leads to many misdiagnoses.

It may resemble viral

or bacterial upper respiratory infections, the painful stiff neck of
meningitis, or the abdominal pains of either appendicitis or hepatitis
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(Dirckx, 1972, p. 45; Hoagland, 1973, p. 99; Thompson, 1969, p. 453).
Wide publication of the association of Infectious Mononucleosis and the
Epstein-Bar Virus has not erased the popular belief that psychological
factors have something to do with the onset of the disease.

Dr. John

Miller, Director of Student Health at Indiana University, stated, "We
see more cases of Infectious Mononucleosis at times of stress, such as
midterms and finals, than at other times of the academic year" (Miller,
1972, p. 56).

The contention that steroid therapy could provide sympto

matic relief for the patients with Mono-Pharyngitis goes back to at least
1956, and the justification for the use of steroid therapy in treating
patients with Infectious Mononucleosis seems to be reasonably well
established in those cases in which fever is clinically manifested.
However, when the symptoms include a Pharyngotonsillitis (as occurs in
some 80 percent of the cases), the effectiveness of such steroid therapy
is subject to controversy (Klein, 1969, p. 446).
No specific therapy is available.

Secondary bacterial invasion

with Streptococcal Pharyngitis, or Vincent’s angina, should be sought
and treated with appropriate antimicrobial drugs,

Symptomatic treat-

ment of the fever and pharyngitis with salicylates and sedation for pain
is indicated when necessary.

Splenic rupture occasionally occurs and

may be heralded by abdominal pain and shock.
for prompt surgical intervention.

This complication calls

Bed rest is recommended for severely

icteric patients and those with other forms of hepatitis.

Adequate

rest and avoidance of activities in which splenic rupture may occur are
important in acute and convalescent periods.

Fluid intake is important.

If a patient is too ill to swallow ice cream, Jello, or cold fluids.
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I.V. dextrose in saline or water may be administered in the hospital
(Barnes, 1974, p. 37; Lyght, 1966, p. 760; Miller, L. , 1972, p. 55;
Valentine, 1969, p. 1159).

Other than occasional focal neurological

residuals reported, complete recovery is the general rule.

(See Appen-

dix A for Mononucleosis pamphlet given to students with Infectious
Mononucleosis by the Student Health Service of California State Univer
sity, Fullerton campus.)

No reference was made as to dietary or nursing

management for the ambulatory patients in the literature.
The University health nurse clinician can be described as one
who shares major responsibility for assessing, planning, implementing.
and validating programs of nursing care, as well as teaching personnel
and participating in nursing research.

She performs these functions

through individual actions, innovation, and collaboration with other
personnel involved in the care of the student.

Nurses, in general, have

come a long way since nursing’s infancy which was marked by a close
paternal relationship with physicians and hospitals, when they were
taught, nurtured, fed, clothed and housed by hospitals employing them
(Dutton, 1969, p. 471; Marram and others, 1974, p. 7).

However, sensi

tive nurses have never limited their roles to the dictates of job
specifications and the status quo when human integrity demanded a
change in role.

Nursing is contributing significantly to improving

health care by expanding its efforts to keep pace with changes in
health care delivery needs (Murata, 1975, p. 149).

The appearance of

a report in 1971 of a committee convened by the Secretary of Health,
Education and Welfare, under the chairmanship of Dr. Roger Egeberg, to
study extended roles for nurses, made it very clear that nurses need.
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can. and want to be prepared for increased responsibility as members of
the health team (Pesch, 1972, p. 838).

Today, physicians and nurses

are collaborating to achieve more effective understanding of one another
in order to redefine their complementary functions of medicine and nurs
ing and to work out practical applications of new relationships (Arding
and others, 1973, pp. 655-657; Murray and others, 1975, p. 108).

A com

parison of available studies on expanded roles of nursing shows that the
These

nurse's influence can be studied in relation to diverse interests.

studies are aimed at improving the patient's knowledge of illness, his
techniques of self-management and satisfaction with medical care.
areas are key factors in compliance behavior of patients.

These

The indica

tions are that the trend is toward redistribution of responsibilities,
including a more active role for the nurse in an outpatient clinic, and
freeing the physician to devote more time to other specific matters.
Some studies deal with cost reduction in administration of health care
(Tagliacozzo, 1974, p. 596).

METHODOLOGY

The patient's comprehension of his problem and individual
psychological coping mechanisms are non-medical variables that affect
patient recovery.

The search for clear factors influencing patient

recovery is compounded in the case of Infectious Mononucleosis because
there is still no specific treatment for this infection.

The compara

tive experimental method of study was chosen to control a factor (nurs
ing care), in order to explore the possible relationships between
systematic nursing management and patient recovery.
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Variables
The independent variable in this study was the systematic nursing
management of the patient with Infectious Mononucleosis and the dependent
variable was the length of time, measured from the patient's entry into
treatment until the level of atypical lymphocytes in the blood reached
20 percent.

Setting
Student Health Service of California State University, Fullerton
campus, was the setting for this study.

The student population at the

time the study was initiated was 21,809.

This population is composed

entirely of off-campus residents and is a homogeneous mixture of all
ethnic and religious backgrounds.
Sample
The sample consisted of students of the California State Univer
sity, Fullerton campus.

However, not all students at the health service

were eligible to be in the study; only those who had an established
diagnosis of Infectious Mononucleosis were eligible.
sisted of two groups.

The sample con-

The first was a control group composed of 12

students selected from the medical records of those previously treated
for Infectious Mononucleosis at this University health service.

They

were selected from the computer print-out of patients with this diagnosis.
starting with August, 1975, and going back as many months as necessary
to find 12 such patients.

The second, or experimental group, was

selected from the students currently seeking diagnosis and treatment
for Infectious Mononucleosis.

As soon as each of their diagnoses was
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confirmed, they were asked to be a part of the study.
subjects gave written permission to be in the study.
for consent forms.)

All experimental
(See Appendix B

The physicians and nurses treating, or caring for.

the experimental students gave verbal consent to the investigator to be
part of the study.

Since the medical records and their confidentiality

were kept in accordance with the policies of the student health service.
the investigator did not obtain written consent specifically for this
study from the subjects of the control group.

The written consent to

treat, given by these patients at the time they sought medical care.
was adequate in terms of record review.
The subjects for this study were selected according to the fol
lowing criteria:

(1) established diagnosis of Infectious Mononucleosis

based on a physical examination by the physician (criteria used to make
a diagnosis were determined by the individual physician), and by lab
oratory data, and (2) the laboratory data must show the level of atypical
lymphocytes to be over 20 percent on the day of patient entry to treat
ment .
The student health nurse, as an important member of the health
team in an ambulatory care setting, works closely with the patient and
in collaboration with the physician in order to institute a systematic
regimen of health care.

Because she is in a unique position to parti-

cipate in the surveillance and management of health care for her
patients, she needs to question and investigate the relationships be
tween nursing management and patient recovery instead of accepting ideas
and knowledge from authorities without question (Dutton, 1969, p. 42;
Notter, 1974, pp. 4-5).

The registered nurses working in the student
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health service at the present time may or may not involve the patients
in the assessment planning, implementation and evaluation of their care.
Therefore, the nurses caring for the experimental group of patients were
given a manual of systematic nursing management to follow, in order to
facilitate adoption of the present system and standardize the nursing
intervention given to patients with Infectious Mononucleosis.
Appendix C for Systematic Nursing Manual.)

(See

A two-hour in-service educa

tion class was conducted in order to present the use of the Systematic
Nursing Manual to the nurses.
The nurses volunteering to work with the experimental group
first triaged all possible cases, waited for confirmation of the diag
nosis, then made a contract with the patients to care for those quali
fying for the sample group.

Laboratory Procedure
Laboratory procedures were performed, according to the orders of
the physicians and nurses, by laboratory technologists employed by the
student health service.
of each patient.

The data was then placed in the medical records

The procedures usually ordered to be performed were:

C.B.C., or at times W.B.C. and differential with the level of atypical
lymphocytes, throat cultures and heterophile agglutination test.
All laboratory procedures carried out in the health service were
conducted according to current laboratory standards set and approved by
the State of California, assuring accuracy in laboratory reports.

Procedure for Collecting Data
The researcher extracted necessary information from student
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medical records, using a prepared data sheet.

(See Appendix D for

data sheet.)
Data Analysis
T-tests at the 5 percent level were performed on the means of
three principle factors associated with the patient's course of illness
(patients' course of illness measured in days, the length of time from
the day of diagnosis to the day the level of atypical lymphocytes
reached 20 percent, and the patients' start of treatment until the
atypical lymphocytes reached 20 percent, measured in days), to determine
whether there was a difference between the experimental and the control
group.
FINDINGS

A distribution of the sample, by age, is presented in Table 1.
No effort was made to control the number of students in the various
categories.

The range of ages for the control group (23-29) was small.

while the ages of the experimental group (19-34) showed a wider spread.
The length of time which the medical personnel take to process
a patient from admission to diagnosis, or from diagnosis to treatment
should be fairly comparable from one year to another.

Since the popu

lation of the control group was selected from students from another
academic year, T-tests were done on both sample groups, in order to
examine any time differences that might have occurred.
Table 2 shows the results of the T-tests performed on the mean
number of days between triage and diagnosis, and the mean number of days
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Table 1
Sample Distribution by Age

Experimental

Total

Age

Control

36-32

0

1

1

31-27

4

1

5

26-22

8

4

12

21-17

0

6

6

12

12

24

Totals

16
between diagnosis and treatment.

The results were not statistically

significant at the 5 percent level, which indicated that the two groups
of patients were processed in approximately the same length of time.
Therefore, both groups of patients from different academic years were
processed through the health service by the medical personnel at a com
parable rate.

Table 2
Comparison of Health Service Processing of Patients
in the Two Study Groups
Mean Number of Days
1.

2.

Number of days between
triage and the day the
diagnosis was confirmed
Number of days between
diagnosis and start of
treatment

Control

Experimental

T

p*

1

3

1.56

.13

1.5

1.47

.16

.5

* P is significant at the 5% level (a=.05)

Table 3 (control group) and Table 4 (experimental group) list
the secondary complications manifested by the sample groups.
shows few complications among the control group patients.

Table 3

However, be-

cause the pharyngeal cultures were omitted on four out of twelve of the
patients, the investigator was unable to come to an unbiased conclusion.
As a result of using systematic nursing management, the experimental
patients uniformly received pharyngeal cultures (Table 4).

This group

of patients manifested a variety of pharyngeal complications and were
treated accordingly.
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Table 3
Types of Pharyngeal Complications Manifested by Patients in
the Control Group During the Course of Their Illness

Total of 12 Patients
Listed by Patient Number
as They Enter the Study

Type of Medication Prescribed
Antibiotics

Steroids

Others

1.

No culture taken

Yes

No

Yes

2.

No culture taken

Yes

No

Yes

3.

Staph. Aureus Coag +

Yes

Yes

Yes

4.

Normal Flora

Yes

No

Yes

5.

Staph. Aureus Coag + many

Yes

No

Yes

6.

Staph. Aureus Coag + many

Yes

Yes

Yes

7.

Normal Flora

No

No

Yes

8.

No culture taken

No

No

No

Yes

No

No

9.- Normal Flora
10.

No culture taken

No

No

No

11.

No Growth

Yes

No

No

12.

Staph. Aureus Coag +

Yes

No

No
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Table 4
Types of Pharyngeal Complications Manifested by Patients in the
Experimental Group During the Course of Their Illness
Total of 12 Patients
Listed by Patient Number
as They Entered the Study

Type of Medication Prescribed
Antibiotics

Steroids

Others

Staph. Aureus Coag. +
heavy growth

Yes

No

Yes

Hemoletic Staph. Aureus
coag + heavy growth

Yes

Yes

Yes

Hemoletic Staph. Aureus
coag + heavy growth

Yes

No

Yes

Beta-Streptococcus, (Group A),
moderate growth

Yes

No

Yes

E- Coli. & Lactobacillus
400 rg/ml

Yes

No

Yes

6.

Staph. Aureus Few

Yes

Yes

Yes

7.

Beta-Streptococcus, (Group A)

Yes

No

No

8.

Beta-Streptococcus, (Group A)

Yes

No

Yes

9.

Normal Flora

No

No

No

10.

Normal Flora

Yes

No

Yes

11.

Staph. Aureus coag +

Yes

Yes

No

12.

Beta-Streptococcus, (Group A)

Yes

No

No

1.
2.

3.

4.
5.
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Table 5 shows a comparison of the patients' course of illness
in terms of the mean number of days, the standard deviations and the
T-test values (cx=5%) .

Although the differences were not significant

(a=.13), there was a 15-day difference between the two groups of patients
in favor of the experimental patients.

Table 5
Comparison of the Mean Number of Days, the Standard Deviations,
and the T-Test Value at 5 Percent Level of the Patients »
Course of Illness
Control

Experimental

Mean Number of Days

45.1

30.4

Standard Deviation

29.5

10.2

T-Test at 5% Level

T-Value

P-Value

1.62

.11

Table 6 compares the relationship between the level of atypical
lymphocytes (measured at the time of the patients' entry to the study).
and the length of the patients' course of illness.

The mean level of

atypical lymphocytes and the mean number of days for the length of ill
ness is also shown.
No correlation was seen between the levels of the patients'
atypical lymphocytes and the course of their illness.

However, the

patients of the experimental group were able to reduce the average
course of their illness to 15 days less than that of the control group
patients.

Table 6
Comparison of the Relationship Between the Sample Population's Course of Illness and
Their Level of Atypical Lymphocytes
Control Group

Patient's Number as
He Entered the Study

Number of Days
Between Triage
and Atypical Lymph.
Reaching 20%

Experimental Group

Level of
Atypical Lymph.

Number of Days
Between Triage
and Atypical Lymph.
Reaching 20%

Level of
Atypical Lymph.

1.

113

25%

30

70%

2.

36

50%

30

90%

3.

17

30%

39

30%

4.

20

30%

39

65%

5.

56

95%

32

50%

6.

25

80%

24

65%

7.

21

30%

13

85%

8.

44

95%

36

65%

9.

46

30%

32

80%

10.

18

30%

49

99%

11.

64

95%

27

90%

12.

81

80%

14

80%

Mean
Days 45

Mean Level of
Atypical Lymph 55%

Mean
Days 30

Mean Level of
Atypical Lymph 72%
ro
o
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Because not all patients began their treatment for Infectious
Mononucleosis on the same day as their diagnosis, the study presented
in Table 7 was made.

Table 7 shows a comparison between the two groups

of the difference in mean number of days from the start of treatment
until the day atypical lymphocytes reached 20 percent.

Although a T-

test showed no significant difference in means (a=.14), there was a 14day difference between the two groups of patients, in favor of the
experimental group.

Table 7
A Measure of the Length of Time from the Day of Diagnosis
to the Day the Level of Atypical Lymphocytes
Reached 20 Percent
Control

Experimental

Mean Number of Days

42.8

28.6

Standard Deviation

29.3

11.5

T-Value

P-Value

T-test (a=.05)

1.57

.14

Table 8 compares the mean number of days of illness of the con
trol group and the experimental group, their respective standard
deviations in terms of the time from when diagnosis was confirmed to
the time the atypical lymphocytes reached the level of 20 percent.

The

results of this comparison, while not significant (a=.ll) also showed a
15-day difference between the two groups, in favor of the experimental
group.
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Table 8
Comparison of the Mean Number of Days, the Standard
Deviations, and the T-Test Value at 5 Percent Level
on the Patients' Start of Treatment Until the
Atypical Lymphocytes Reached 20 Percent
Control

Experimental

Mean Number of Days

42.5

27.0

Standard Deviation

29.1

11.0

T-Value

P-Value

1.73

.11

T-Test (a=.05)

Table 9 compares five other factors associated with measuring
the illness continuum.
1.

They were:

The number of days between start of treatment and end of

treatment.
2.

The number of days from date of diagnosis until the atypical

lymphocytes were more than 20 percent.
3.

The number of days from start of treatment until atypical

lymphocytes reached more than 20 percent.
4.

The number of days from the time that the atypical lympho

cytes were more than 20 percent to when they became less than 20 percent.
5.

The number of days from the time the atypical lymphocytes

were less than 20 percent until the end of treatment.
T-tests were performed comparing the means of these five factors
for experimental and control groups.

Although the differences between
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experimental and control groups were not statistically significant for
any of the five factors (probably due to the small sample size), the
experimental group of patients recovered, on the average, faster than
the control group.

Table 9
T-Tests Performed on Five Factors Associated With
Measuring Illness Continuum of Patients

Mean Number of Days
Number of days between start
of treatment and end of
treatment

Control

49

Number of days from date of
diagnosis until atypical
lymphocytes were more than
20%

1.5

Number of days from start of
treatment until atypical
lymphocytes were more than
20%

1.6

Experi
mental

T

P*

41

.79

.44

2

.63

.54

1.09

.29

.66

Number of days between the
time when atypical lympho
cytes reached more than
20% to when they became
less than 20%

43

26

1.79

.09

Number of days from the time
when atypical lymphocytes
were less than 20% to end
of treatment

4

15

1.43

.17

* (a=.05)
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Table 10 shows a comparison of the two sample groups in common
physical manifestations of Infectious Mononucleosis.

Table 10
A Comparison of Common Physical Manifestations of the Two
Sample Groups on the First Day of Triage
Frequency of Symptoms Shown
by Number of Patients
Control

Experimental

12

10

Fatigue

9

9

Fever—over 99° F.

5

5

Pharyngitis—without exudate

5

3

Lymphadenopathy—Post Cervical Triangle

2

3

Tonsillitis—without exudate

2

2

Pharyngitis—with exudate

1

2

Tonsillitis—with exudate

1

5

Morbilliform Skin Rash

2

2

Splenomegaly

1

2

Jaundice

0

1

Hepatomegaly

0

0

Physical Manifestations
Lymphadenopathy—Cervical
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Table 11 shows the number of patients treated for secondary
complications.

The types of secondary complications manifested by the

patients were mostly pharyngeal (see Table 3, p. 17, and Table 4, p. 18,
for types of complications).

Steroids were given when secondary compli

cations added to the severity of the symptomatology and the discomfort of
the patient.

Table 11
Number of Patients Who Took Medication for Secondary
Complications During the Course
of Their Illness
Control

Experimental

Antibiotics

9

11

Steroids

2

5

Vitamins

3

2

Others

7

7

Types of Medication

Table 12 compares the difference in the amount of recording done
by the nurses caring for patients in the two groups.

An absence of a

comment on a chart did not necessarily indicate that any particular step
in the treatment process was omitted.

The nurses caring for the patients

in the experimental group generally followed the instructions in the
manual and charted most medical findings and nursing procedures.

There

were a few instances when charting was not done in the experimental group.
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Table 12
Comparison of Charting by Nurses
Control
No
Charting

Experimental
No
Yes No Charting

Yes

No

12
2

0
0

0
10

12
12

0
0

0
0

1
0

0
1

11
11

11
10

0
0

1
2

0
0

0
0

12
12

12
5

0
1

0
6

1*

0

11

12

0

0

2

0

10

12

0

0

1*
1*
1*
1*
1*
0
1*
1*

0
0
0
0
0
0
0
0

11
11
11
11
11
12
11
11

12
12
12
12
12
5
6
4

0
0
0
0
0
3
3
4

0
0
0
0
0
4
3
4

1*

0

11

12

0

0

0
1*
1*

0
0
0

12
11
11

12
10
4

0
0
0

0
2
8

Nursing Assessment;
1. Physical assessment
2. Nutritional assessment
3. Social and environmental
assessment
4. Class workload assessment
Nursing Care Plan:
1. Make contract with patient
to be his nurse during
course of illness
2. Set up nursing objectives
Patient Education:
1. Mention: Diet, Nutrition
2. Give pamphlet on
Mononucleosis
3. Advise viewing audiovisual
aids
4. Discuss lab tests
5. Discuss course of illness
6. Discuss rest and activity
7. Discuss medication
8. Notify professors
9. Notify family
10. Notify employer
Evaluation of Compliance to
Regimen:
1. Review patient's record
2. Record patient's compliance
with regimen
3. Record compliance of nurse
4. Record family compliance

* This charting was the result of one nurse's input for one patient.
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Table 13 shows the number of times the nurses and the physicians
saw their patients by setting up an appointment to perform physical
examinations, do counseling, or evaluate laboratory results.

Introduc-

tion of systematic nursing management to the nurses caring for the
experimental group of patients caused a significant reduction (pc.06) in
the number of appointments made for the physician treating the patients
with Infectious Mononucleosis.

The change can be summarized by comparing

the mean number of appointments made by the two respective groups of
care givers.

Nurses caring for the experimental, group of Infectious

Mononucleosis patients doubled their appointments, while the physicians
treating the same group of patients reduced their appointments for
Infectious Mononucleosis patients by 31 percent.
DISCUSSION

Findings of this study are not conclusive.

This study showed

that six cases of Infectious Mononucleosis did occur in people over 27
years of age.

Nurses must be careful, in considering all aspects of

patient screening,, before dismissing a patient as being too old to mani
fest the symptoms of Infectious Mononucleosis.
Close examination of the data taken from this study shows that
the systematic nursing management guide (manual) was the major factor
in contributing to the uniformity of care given by the nurses to the
patients in the experimental group.

For example, nurses following the

systematic nursing guide all took their patients' pharyngeal cultures
(Table 4).

Ten out of twelve patients showed secondary complications

of the pharynx and were treated with appropriate drugs.

On the other
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Table 13
Comparison of Nurse-Patient and Physician-Patient
Appointments for the Sample Population*
Number of
Appointments
With Each Patient

Mean Number of
Appointments
For Each Patient

Number of Nurses

o

o

M

O

4
3
2
2
1

1
3
4
2
6

2.58

3
4
5
6
8
10
11

5.33

4
5
6
7

6.15

2
3
4
6
8

3.66

r—I

o

5-(

Number of Doctors

■U

a

oo

4
3
1
1
1
1
1

Number of Nurses
a
3
o
5-i
o
t—I
■I-)

4
4
2
• 2

C
05

e

•H
H
05

w

Number of Doctors
5
2
2
2
1

* Difference for nurses was significant p<.01
Difference for doctors showed p<.06
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hand, nurses caring for the patients in the control group were not
given a manual to follow.

Four out of twelve patients did not have

their pharyngeal cultures taken, and two out of those patients received
antibiotic treatment for secondary complications which involved the
pharynx.

Justifications for omitting the cultures were not recorded

(Table 3, p. 17).
Throughout the nurses' notes for the experimental group of
patients, the evidence of systematic nursing management was easily
detected.

Precise charting was continued until the Infectious Mono

nucleosis patients were discharged from care.

Although this study did

not place its emphasis on nursing audit, the systematic nursing manual
provided a guide for uniform documentation which led to effortless,
successful auditing of the nursing records.
Although the experimental group manifested a higher level of
atypical lymphocytes than the control group at the beginning of their
treatment (Table 6, p. 20), these findings were not conclusive.

How

ever, a comparison of the mean number of days illness between those
patients in the experimental group and those patients in the control
group showed fifteen days difference in favor of the experimental group
(Table 5, p. 19).

Comparison of Tables 12 and 13 showed data signifi

cant to nursing performance.

The nurses caring for the experimental

group of patients generally followed the instructions for systematic
nursing care and kept precise notations.

The data showed through

systematic nursing care these nurses were able to increase their Infec
tious Mononucleosis patient appointment load by 100 percent.

At the

same time, physicians treating the experimental group of patients were
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able to reduce their Infectious Mononucleosis patient appointment load
by 31 percent, thus freeing the physicians to devote time to other
matters requiring their attention.

The effect on the total nursing

workload was not evaluated.
It is possible that other variables were confounding the total
picture.

The small sample size together with the large variability in

the illness level of the patients could have contributed to a distor
tion of the results.

In a larger sampling using patients with a closer

illness level in the two groups the results might not follow those
found in this study.
CONCLUSION
The data from this study showed the findings to be in the pre
dicted direction of the hypothesis that a patient with Infectious
Mononucleosis who receives systematic nursing management throughout the
course of his illness will, on the average, show a decreased length of
illness.

Although limitations were placed on the research, nursing

implications were significant.

The course of Infectious Mononucleosis

in the experimental group averaged 15 days less than those patients in
the control group.

Nurse clinicians, working in a university health

environment with physician collaboration, did reduce the period of their
patients’ illness through systematic nursing management.
RECOMMENDATIONS FOR FURTHER STUDY

As a result of this study, the following recommendations are
made:

31
1.

Repeat the study, using a larger sample population.

2.

Repeat this study on other California State University

campuses.
3.

Do further studies, controlling variables such as age.

degree of illness at the beginning of the study, measure the relation
ship between the factor of stress and Infectious Mononucleosis.

NURSING IMPLICATIONS
A nurse clinician working in a university student health service
with physician collaboration should design, implement, and evaluate a
system of nursing management (for patients with Infectious Mononucleosis)
in their ambulatory care setting.

This type of systematic patient

management plan can be easily devised by nurse clinicians in a primary
care setting to be used with patients having other illnesses, such as
diabetes, hypertension, cystitis, etc.
Nursing audit can be enhanced by such a patient management plan.
The systematic nursing management manual not only provides criteria for
uniform patient care, but also establishes a reliable means with which
to evaluate the process of nursing care.

I
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QUESTIONS AND ANSWERS ON MONONUCLEOSIS
by
William H. Wickett, Jr., M.D.
Medical Director, Student Health Center
California State College, Fullerton
1.

What Is Mononucleosis?
Infectious mononucleosis, usually known as "mononucleosis" or simply
"mono," is an acute self-limited disease characterized by irregular
fever, sore throat, swelling of the lymphatic glands, and having
characteristic blood cell and blood serum changes. Although the
disease was first described in 1889 as "glandular fever," it was not
until 1920 that it was called "infectious mononucleosis." Greatest
interest in mono dates from the first careful description of certain
of the blood changes in 1932.

2.

What Causes It?

How Is It Spread?

It is believed that mono is infectious, but to date no causative agent
has been found; however, some aspects of the disease make us suspect
that a virus is involved. The disease is particularly common in
young people of college age. It affects twice as many men as it does
women. The mode of spread is thought to be by direct transmission of
saliva such as by kissing or by sharing soft drink bottles. Trans
mission through the air is possible, but roommates rarely catch it if
one of them is sick with mono. It has been suggested, however, that
some people may be carriers of mono. The incubation period for the
sporadic type of mono is said to be between 4 and 7 weeks from contact
to the first symptoms. There seems to be no particular seasonal inci
dence.
3.

What Are The Symptoms And Signs?
Most typically the onset of mono is vague, indefinite, and similar
to the beginning of other infectious diseases. This first stage
lasts 3 to 5 days. Next comes the active stage in which the patient
may complain of any or all of the following symptoms: chills, sweats,
fever, dizziness, sore throat, headache, aching behind the eyes,
puffy eyelids, general body aching, fatigue, swollen neck glands,
and inability to concentrate. Sometimes, however, the sore throat
and enlarged neck glands are quite minimal, with presenting symptoms
similar to influenza. The majority of "exposed" individuals do not
become ill at all and may have the disease in such a mild form as to
be quite unaware of its presence. Others may just feel "under par"
for a period of time. The active stage of mono lasts from 7 to 21
days in most cases.
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4.

Is There Danger Of Complications?
The chance of complications is quite small. The liver is affected to
some degree in all cases, so this is not considered a complication.
In occasional cases the liver is affected enough to produce jaundice.
The luckily is not the same as infectious hepatitis. In almost all
cases the liver involvement is unimportant and can be expected to
disappear in a short time without permanent liver damage. Abnormal
liver function tests are the expected finding and need cause no con
cern.
The spleen is usually enlarged somewhat, and occasionally it will
become so enlarged that even moderate exertion or a blow to the abdo
men may cause the spleen to rupture, resulting in severe internal
hemorrhage. Significant enlargement of the spleen may be readily
detected by the physician. Regular supervision by the physician is
important even in mild cases.
The acute disease usually lasts from one to three weeks (occasionally
four); and, as a rule, subsides without any problems.
There are no after-effects following the usual attack of mono. How
ever, a generalized fatigue or "under par" feeling with mental
depression and difficulty in concentration may occasionally be exper
ienced for as long as three to six weeks. Recent research at the
University of Colorado Student Health Center has shown that most
patients who have prolonged periods of fatigue and depression fol
lowing mononucleosis are likely to have basically depressive emotional
patterns. Recurrences of mono after recovery are extremely rare;
however, for a period of many months many acute virus infections may
cause a return of fatigue, glandular swelling and some of the changes
in the white blood cells similar to those of acute mono. Such cases
do not represent active mono.

5.

How Is It Best Diagnosed?
The diagnosis of mono is not difficult after the disease has fully
developed; however, it may be exceedingly difficult to diagnose in
some cases during the first few days after onset, since mono imitates
many other acute diseases. The diagnosis is made on the basis of the
(1) symptoms of fatigue, sore throat, etc.; (2) the physical signs
of the mouth and throat, swollen lymph glands, enlarged spleen, etc.;
(3) the finding of a larger than normal number of lymphocytes, of
heterophile (sheep cells) test on the blood serum. Many other lab
tests are needed from time to time to keep the doctor informed as to
the state of his patient.

6.

Is There Not Some Specific Cure For This Disease?
To date there is no specific cure—probably this is because the cause
of mono may be viral in nature. The body builds up its own defenses
and will overcome the disease in its own way. Antibiotics, such as
penicillin, the "mycins," etc., have no effect on mono.
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When fever is present the first essential is bedrest, preferably in
the hospital, until the temperature has been normal for a day or two.
The patient should remain away from classes for a few days longer.
Prolonged bedrest after the acute phase is over is practically never
used, as it may actually prolong the recovery.
Relapses do occur, Such relapses seem to be more common when the
patient returns to school too soon.
7.

Must Most Students With Mono Withdraw Or Reduce Their Work Load?
No; however, some students, particularly those who are depressed,
become discouraged and panicky and withdraw needlessly. Only a few
find it necessary to drop out. Most are able to make the extra
effort to make up their academic work.
Sports, particularly those involving vigorous exercise or body con
tact, are prohibited even in mild cases until the doctor finds that
the spleen is no longer enlarged.

.
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Dear Student,
The ailment for which you are seeking medical help has
been diagnosed as Infectious Mononucleosis. The Student
Health Center at California State University, Fullerton, is
participating in a study to evaluate the effect of systematic
management of nursing care on patients diagnosed with Infec
tious Mononucleosis.
You will be asked to make a decision involving your
voluntary participation in this research program. Please
take the time to read and evaluate the following information.
It will help you to make an informed choice as to whether or
not you wish to take part in this experimental research
program.
Please feel free to direct any question you may have to
the attending nurse or physician after you have read this
information.
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THE EFFECT OF SYSTEMATIC MANAGEMENT OF NURSING CARE
ON PATIENTS DIAGNOSED WITH INFECTIOUS MONONUCLEOSIS
AT CALIFORNIA STATE UNIVERSITY, FULLERTON
STUDENT HEALTH CENTER

Infectious Mononucleosis is an acute self-limiting disease
characterized by irregular fever, sore throat, swelling of the
lymphatic glands, and having characteristic blood cell (atypi
cal Downey cell) and blood serum changes. The cause was un
known until about 1968 when the Epstein-Bar Virus was isolated.
Although Infectious Mononucleosis can be found in children and
occasionally in older people, most patients with this disease
range from 15-25 years of age.
Due to its viral cause, there is still no specific drug
to combat this disease and one must treat the patient sympto
matically and rely upon his clinical condition. In contrast
to the dramatic results of surgical intervention, the efforts
of a nurse are less conspicuous, and are quite likely to be
overlooked in the welter of activities that go on in most
health care settings. Everyone knows that nurses are vital
to the health process, but as yet the effect of nursing care
has never been measured on patients diagnosed with Infectious
Mononucleosis.
In order to evaluate total patient care, it is important
for health professions to know if the nurse’s professional
intervention for the patient with Infectious Mononucleosis
can significantly reduce the time course of the illness, The
purpose of this study is to investigate nursing intervention
as related to the effect on the patient's course of illness
and on his rate of recovery from Infectious Mononucleosis.
If you choose to participate in this experimental research,
the Registered Nurse assigned to the experimental group with
physician collaboration will involve the patient in the assess
ment, planning, implementation and evaluation of your nursing
care. She will be the only nurse responsible for providing
systematic nursing which will include:
1.
status.

Making the initial assessment of the student's health

2. Observing, listening, and evaluating the student and
his needs, interpreting laboratory tests for progress
according to defined procedure.
3. Giving professional guidance and taking responsi
bility for direction, including teaching and counseling.
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4. Channeling the student to the physician for diagnostic
study and treatment.
5.

Planning and coordination of nursing and other health

6.

Assure continuity of health care.

care.

In short, the Registered Nurse assigned to you will guide
and assist you in understanding your course of illness and your
medical and nursing care in a systematic manner with physician
collaboration.
Your confidentiality will be protected at all times and at
no time will you be required to undergo laboratory tests that
are not ordered or advised to take medications that are not pre
scribed by the physician. You may withdraw your name at any
time from this study if you wish for any reason. There will be
no financial burden attached with this study.
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PATIENT CONSENT FORM

I, the undersigned, have read the information on the
experimental research program being conducted at this center
on the effect of systematic management of nursing care on
patients diagnosed with Infectious Mononucleosis, I understand:
That the purpose of the study is to investi
gate nursing intervention as related to the effect
on the patient's course of illness and on his rate
of recovery from Infectious Mononucleosis.
That I will be asked to visit the Student
Health Center regularly during the course of the
study, and that I will be required to furnish blood
specimens periodically for laboratory examination
ordered by the physician.
That the medical record and its confiden
tiality will be kept in accordance with the poli
cies of the Student Health Center.
That I am free to withdraw from the study at
any time, for any reason.
I hereby agree to volunteer as a subject in the program,
and furthermore consent to allow the principal investigator,
Lillian N. Yelton, R.N., or any of the physicians, nurses or
assistants working under this program to assist me in my care
of Infectious Mononucleosis.

Signed

Date

Signature of Witness

Date

o xiaNaddv

MANUAL
for Systematic Nursing Management
of
University Students with Infectious Mononucleosis

by
LILLIAN N. YELTON, R.N.

September 1975
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FOREWORD

The chief purpose of introducting this systematic patient manage
ment manual is to provide a guide to be used in caring for patients with
Infectious Mononucleosis during the research study.
This plan reflects all aspects of Infectious Mononucleosis care.
and involves a system of individualized patient care in collaboration
with the physicians.
The principal researcher is providing a vehicle that will allow
nurses to develop skills at the highest professional level, and at the
same time establish criteria for patient care evaluation.
The researcher’s grateful acknowledgement is extended to the
personnel of the Student Health Service, California State University,
Fullerton.

Their valuable assistance, helpful suggestions, and concern

in developing this plan for systematic patient management are appreciated.

Lillian N. Yelton, R.N.

September 1975
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INTRODUCTION
The following instructions are based on the nursing process.
This is the system by which the nurse identifies, plans, and implements
It is a problem-solving process which

the nursing care of the patient.
can be defined in three steps:
III.

I.

I.

Assessment;

II.

Intervention; and

Evaluation.

Assessment

Assessment is a complex phase in which data
concerning the patient are collected and sorted
into appropriate problem areas

II.

Intervention

Intervention consists of both planning and
giving care, with the patient’s problem in
mind.

Nursing objectives are formulated as

statements of desired outcomes in patient
behavior as a result of nursing care
III.

Evaluation '

Evaluation is the phase of the nursing process
in which the nurse uses measurable criteria to
learn whether or not the nursing objectives
were accomplished

CHARTING
The present system of problem oriented recording (including the
problem sheet), will be used to record all notations.

This system has
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been effectively in use at the Student Health Service for over five years.
Therefore, there will be no further instructions on charting.

PROCEDURE
STEP I.
A.

PATIENT ASSESSMENT
DEFINITION.

The data base includes history, physical examination

and laboratory data.

When the data base is accurate and complete.

the nurse has the opportunity to interpret the facts accumulated
and make a good problem list for her patient.
B.

THE COMPLETION OF PHYSICAL ASSESSMENT.

(See Part I of the Assess-

ment Form.)
1.

The initial physical assessment by the nurse in the triage
will include:
a.

Physical examination (problem oriented)

b.

W.B.C. and Diff. (including the level of the atypical
lymphocytes)

C.

c.

Pharyngeal culture

d.

Problem oriented medical history

THE COMPLETION OF A NUTRITIONAL ASSESSMENT.

(See Part II of

Assessment Form.)
D.

THE COMPLETION OF A SOCIAL AND ENVIRONMENTAL ASSESSMENT.
Part III of Assessment Form.)

E.

FORMULATE A PROBLEM LIST

(See
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STEP II.
A.

IMPLEMENTATION OF THE NURSING CARE PLAN

DEFINITION.
process.

Planning the care of a patient is a multi-faceted

Once objectives for the care have been formulated by

careful review of the problem list, the next step is to contrive
various nursing approaches which might help achieve the goals.
Ideally, the selection of alternative approaches should be done
with patient collaboration.

Your past experiences are helpful

resources for possible approaches, as well as indicators of the
plan's possible success.

Nursing plans should show that the

nurse did consider the physical, mental, emotional, spiritual.
social, and environmental needs of patients.

Nursing actions

should represent a variety of nursing measures:

observing, com

forting, counseling, teaching and referring.
1.

As soon as the diagnosis of Infectious Mononucleosis is confirmed, make contract with the patient to be his nurse
during the course of his illness and until he is discharged
from care for this problem.

2.

Explain to the patient about this Infectious Mononucleosis
research, and ask him to give consent to join the study.
The patient must sign a written consent form provided by the
researcher.

3.

With physician collaboration, review physical findings,
medical history, and laboratory reports to plan course of
treatment.

Involve the patient in all phases of health

care planning.
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4.

After completion of the medical and nursing plan, record
nursing objectives in the patient's medical record.

Short

and long-term objectives should be written.
5.

Laboratory procedures.

After initial laboratory procedures

have been completed, in order to evaluate the patient's
course of illness, order the following laboratory tests:
a.

W.B.C. and Diff., every week until the level of atypical
lymphocytes reaches 20 percent, and then P.R.N.

b.

Repeat pharyngeal culture, if patient was placed on antibiotic therapy for secondary complications of pharyngitis.
(Repeat pharyngeal culture 10 days after the treatment.)

c.

Other laboratory tests such as Sed. rate, Sgot., Sgpt.
should be done after consultation with the physician.

6.

Arrange with your patient for a minimum of one appointment a
week to discuss the patient's problems, progress, care, and
evaluation (allowing time for patient education).

7.

With patient's consent, notify his family, roommate, professors, and employers of his illness.

If necessary, refer him

to other agencies.
8.

Patient education by nurses should include the following:
a.

Give the patient an Infectious Mononucleosis pamphlet
and discuss it with him.

b.

Explain the course of illness, the severity of the disease.
and warn the patient of the possible complications of
hepatitis and jaundice, splenomegaly, ruptured spleen.
hepatomegaly and others.
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c.

Discuss laboratory tests and test results, explain to
the patient, in general, the names of the tests, the
reason for the tests, and the frequency of tests.

d.

Advise the patient to view sound-over-slide (audio visual)
Infectious Mononucleosis information available in the
student Health Center and the Audio Visual Center on
campus.

Arrangements can be made through Dr. Wickett's

secretary.
e.

Discuss diet and nutrition with the patient.

Collaborate

with the physician as to the type, amount and frequency
of food to be eaten by the patient.

(See attached diet

information sheet.)
f.

Discuss medication regimen, if any, with the patient.
Review with the patient:

when to take medication, dosage.

the rationale, and the signs and symptoms of undesirable
reactions and complications.
g-

Discuss with patient rest and activities and other regi
men associated with sleep.

STEP III.
A.

EVALUATION OF THE RESULTS OF NURSING MANAGEMENT

DEFINITION.

Evaluation is the phase of the nursing process in

which the nurse uses measurable criteria to learn whether the
nursing objectives were accomplished.
B.

CHECK LIST TO BE USED IN EVALUATING RESULTS OF SYSTEMATIC MANAGEMENT OF NURSING CARE:
1.

Assessment
a.

Physical assessment done?

Yes

No

Comments
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Yes

2.

3.

4.

b.

Nutrition assessment done?

c.

Social and environmental
assessment done?

d.

Class work load assessment done?

No

Comments

Nursing Care Plan
a.

Contract made with patient to
be his nurse during this course
of illness?

b.

Nursing objectives written?

Patient Education
a.

Diet and nutrition discussed?

b.

Infectious Mononucleosis
pamphlet given to patient?

c.

Advice given to view Infec
tious Mononucleosis soundover-slide information?

d.

Laboratory test and test results
discussed with patient?

e.

The course of illness and pos
sible complications discussed?

f.

Rest, sleep and activities
discussed?

g*

Medications discussed with
patient?

h.

Professor notified?

i.

Family notified?

j•

Employer notified?

Evaluation of Compliance to Regime:
a.

Record review done by nurse?

b.

Your nursing objectives
accomplished?

No
Charting
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Yes
c.

Record shows charting of patient
compliance?
good
(patient kept all appointments
and adherence to regimen was
documented.)
moderate____________
(patient missed two appointments
and adherence to regimen was
documented.)
poor
(patient missed three appointments
and/or failed to adhere to regimen. Document.)

d.

Professor compliance regarding
study load?

e.

Family compliance?

f.

Compliance by nurse?
good_
(followed the manual)
moderate_____________
(missed three of the required
procedures)
poor
(missed five or more of the
required procedures)

5.

Your recommendations for improvement
of systematic patient management:

No

No
Charting
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ASSESSMENT FORM, PART I
1.

(PHYSICAL ASSESSMENT)

Complete the medical history (problem oriented) according to the
triage manual of the Student Health Center.

2.

Record findings.

Complete the physical examination (problem oriented) according to
the triage manual of the Student Health Center.

Include the clinical

manifestations listed below which are typical of those manifested by
Infectious Mononucleosis patients.

(Check whether present or not

present.)
present
fever
lymphadenopathy - cervical
lymphadenopathy - post cervical triangle
lymphadenopathy - axilla
pharyngitis

- s exudate

pharyngitis

- c exudate

tonsillitis

- s exudate

tonsillitis

- c exudate

splenomegaly
hepatomegaly
jaundice
fatigue
weakness
malaise
arthralgia
nausea

not
present
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present

not
present

vomiting
rash on body (morbilliform skin rash)
3.

Send the patient to the laboratory for:

W.B.C. and Diff. (need

report on the level of the atypical lymphocytes) and take a pharyn
geal culture.
4.

Refer patient to physician for diagnosis.

The diagnosis of Infec-

rious Mononucleosis is confirmed by:
a.

Physical examination (patient's clinical manifestations)

b.

Laboratory tests (especially the level of the atypical lymphocytes).

For the purpose of this study, the patient's level of

atypical lymphocytes at the time of triage must be at least 20%
to confirm the diagnosis.
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ASSESSMENT FORM, PART II

(NUTRITIONAL ASSESSMENT)

Male and female dietary requirements are met by sound diet, based on
the Basic 4 food groups.
several factors:

Male and female caloric intake is based on

occupation, amount of physical activity or mental effort.

emotional state, age, body size, climate, and individual metabolism.

It

is essential for the nurse to make accurate nutritional assessment of her
patient with Infectious Mononucleosis in order to help restore him to
good health.
Nutritional History-Diet Pattern
Food likes
Food dislikes
Food allergies
Who prepares the food?
Meals/day

Snacks/day

Bread &
Cereal

Breakfast

Snack
Lunch

Dinner

Snack
Total
Intake
Comments

Money spent on food/week
Eat Out Number of Times/Week

24-hour diet recall
Meat, Eggs
Vege
Fruits
Legumes
tables

Milk &
Cheese

Other
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ASSESSMENT FORM III

(SOCIAL AND ENVIRONKENTAL ASSESSMENT)

Planning of patient care is dependent upon a body of information
about the patient, his family and his environment.

This information

points out the need of the patient for nursing care and serves as a basis
for planning (L. Lewis, Planning Patient Care, p. 35.)

Show the Proper Classification
Housing:

Apt.

Marital Status:
Living with:

House
Married

Family

Trailer
Not married

Other People (roommate)

Miles traveled by student per day
Means of support:

Other

Parents

.

Alone

By car

Self

Bus

Other

Self and other

Does religious affiliation dictate style of living?
Other significant factors
Load of work:

Total class units
Type of classwork very stressful?

Yes

No

If yes, reason
Physical activity—type, how much/day?

Sleep and rest habits—hours of sleep
Type of work after school:
Manual work?_____
Homemaker ?_____
Hard labor?_____
Sit down type job?_____
Time of work— A.M.___ P.M.
Other
Work environment:

Night

Week-ends

outside, exposed to weather?_____
inside but exposed to heat or cold
heated/air conditioned building___
well protected___

DIET INFORMATION FOR PATIENTS WITH INFECTIOUS MONONUCLEOSIS
Diet is flexible and may be adjusted 'to your individual eating habits. You should eat regularly, avoid
all fried and highly seasoned foods such as pizza, sandwiches made from spicy lunch meats or greasy potato
chips. Make sure some type of protein is included in each meal. Do not overeat at any meal.
FOODS PERMITTED

FOODS TO OMIT

MILK

Whole milk, nonfat milk, buttermilk, malted
milk.

None

EGGS

Poached, scrambled, soft or hard boiled,
baked, creamed, plain omelet or souffle.

Eggs fried in grease or oil.
butter or vegetable oil.

CHEESE

All cheeses except cheese with added
spices or seeds.

Any cheese with added spices or seeds.

MEATS

Ground or tender beef, veal, lamb, fresh
pork, liver, chicken, turkey. All meats
should be broiled, boiled or roasted.
Baked, broiled or steamed fish, such as
cod, halibut, flounder, perch, haddock.

Bologna, luncheon meats, sausage, frankfurters, ham
and all salted and cured meats, except crisp bacon
may be used. All fried meats, fish, and fowl.

Potatoes—mashed, boiled, or baked—
VEGETABLES
do not eat the skin. Cooked or canned
asparagus tips, green beans, beets,
carrots, squash, canned peas, spinach,
sweet potatoes, mushrooms, pumpkin,
cabbage, cauliflower, onions, broccoli,
tomatoes.
FRUITS

Canned or cooked peaches, pears, apple
sauce, peeled apricots, baked apples
without skins or seeds, royal anne cherries,
ripe bananas, avocados. All fruit juices
without pulp. All fresh fruits as
tolerates.

Eggs may be fried in

Raw cabbage, cauliflower, onions, broccoli,
cucumbers, green peppers, radishes. Shredded
lettuce may be used if tolerated.
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FOODS PERMITTED

FOODS TO OMIT

SOUPS

Cream soups made with allowed vegetables
permitted; broth, bouillon, consomme.

Highly seasoned soups.

Read label for contents.

BREAD &
CEREALS

White and whole wheat bread. Refined
cooked cereals such as Cream of Wheat,
Cream of Rice, Malto Meal, farina, oat
meal. Puffed rice, puffed wheat, corn
flakes. Crisp waffles. White rice,
noodles, macaroni. Saltines, crackers
without seeds, graham crackers, whole
grain cereals.

Rye bread, any bread with seeds. Any cereal con
taining bran. Hot breads, rolls, pancakes (may be
eaten in moderation).

DESSERTS

Jello, gelatine, custard, plaid puddings,
ice cream, sherbet without seeds, plain
cakes and cookies.

All rich pies, pastries, candies, chocolate. Pies
made with berries. Any dessert with coconut, seeds
or nuts.

SWEETS &
Jelly without seeds. Sugar, syrup,
SPICES
honey, molasses, plain candy. Cinnamon,
salt.

Preserves or jams with seeds, Candy made with
chocolate, coconut or nuts. Pepper.

FATS

Butter, oleo, mayonnaise, cream, crisp
bacon, smooth peanut butter.

Highly seasoned gravy or spices. Seasoned salad
dressings. Nuts, crunchy peanut butter.

BEVERAGES

Any noncarbonated, nonalcoholic
beverage. Coffee substitutes. Decaf
feinated coffee. Weak tea. Fruit
juices without pulp. Tomato or citrus
juices should be taken at the end of
the meal or sipped slowly during the
meal.

Regular coffee. Strong tea, cocoa. Alcoholic and
carbonated beverages---- unless approved by physician.

CTn
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RESEARCH DATA COLLECTION
INFECTIOUS MONONUCLEOSIS
CALIFORNIA STATE UNIVERSITY STUDENT HEALTH SERVICE
FULLERTON, CALIFORNIA
by
Lillian N. Yelton, R.N.
CSUF Student #

LLU Computer #
Control Group
Experimental Group
Name of Patient:

First

Last

Middle

Phone:
Address:

DEMOGRAPHIC DATA
female

1.

sex:

2.

marital status:

3.

birth year:

4.

date of triage for this condition:

5.

date of Dx:

6.

date of treatment started:

7.

date of treatment ended:

8.

date of atypical lymphocytes over 20%

9.

date of atypical lymphocytes less than 20%

male

not married

married

% of atypical lymphocytes

10.

date of relapse if any:

11.

date of recovery from relapse:

12.

total length of treatment in weeks:

13.

level of atypical lymphocytes:
low: atypical lymphocytes between 20-24%___
medium: atypical lymphocytes between 25-49%
high: atypical lymphocytes over 5C%_________
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PATIENT CARE DATA
Medical Diagnosis by Physician:
Name of Physician
Clinical Manifestations:
14.

fever

15.

lymphadenopathy - cervical

16.

lymphadenopathy - post cervical triangle

17.

lymphadenopathy - axilla

18.

pharyngitis

- S exudate

19.

pharyngitis

- C exudate

20.

tonsillitis

- s exudate

21.

tonsillitis

- c exudate

22.

splenomegaly

23.

hepatomegaly^

24.

jaundice

25.

fatigue

26.

weaknes s

27.

malaise

28.

arthralgia__ ^

29.

nausea

30.

vomiting

31.

rash on body (morbilliform skin rash)

not present

present

Instruction by Physician:
Physical activities
32.

Rest—Mention the importance of rest,
increase sleep time, etc?

33.

If rest or sleep hours increased, how
many hours over the usual 8 hours
sleep ?________

yes

no

no
charting
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Nutrition
34.

Diet-Food—Mention addition or deletion of
food from diet? Give a diet to follow?

35.

If diet given what kind?
Medication

36.

Medication given (Rx only)?
If yes, name or Rx and dosage.

37.

Antibiotic

38.

Steroids

39.

Vitamin

40.

Other
Contacts in behalf of student

41.

Professor notified as to patient’s
illness by health center personnel
or by the patient?

42.

Patient’s family or extended family
(roommate) notified by health center
personnel or by the patient?

43.

Employer notified as to patient's
illness by health center personnel
or by the patient?
Patient Education by Physician:

44.

Infectious Mononucleosis pamphlet
given to patient to read?

45.

Advised to view sound-over-slide
information on Mononucleosis avail
able in audio visual?

46.

Laboratory test and test results
explained to the patient in general
(name of test, frequency, reason
for testing, etc.)

47.

Discussion about Atypical Lymphocytes?

48.

Discussion about Heterophile titer?

yes

no

no
charting
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yes
49.

Discussion about other tests?

50.

Explain the course of illness or discuss
the disease with patient?
Hepatitis/jaundice
Splenomegaly
Ruptured spleen
Hepatomegaly

51.

Reduced class hours?
present semester units
reduced semester units

52.

Occupation after class work?
If allowed to work after school
how many hours per day?_________
NURSING CARE

Nursing Assessment;
1.

Physical assessment done?

2.

Nutrition assessment done?

3.

Social and environmental assessment done?

4.

Class work load assessment done?

Nursing Care Plan:
5.

Make contract with patient to be his
nurse during course of illness?

6.

Nursing objectives?
Patient education

7.

Diet/Food/Nutrition mentioned?

8.

Infectious Mononucleosis pamphlet
given to patient?

9.

Advised to view sound-over-slide
information available in audio
visual?

10.

Laboratory test and test results
discussed with patient?

11.

Discussed the course of illness and
possible complications with patient?

no

no
charting
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yes

12.

Rest/Activities/Sleep mentioned?

13.

Discussed medications with patient?

14.

Professor notified?

15.

Family notified?

16.

Employer notified?

Evaluation of Compliance to Regime:
17.

Record review done by nurse?

18.

Record shows charting of patient
compliance?

good
moderate
poor
19.

Professor compliance regarding study
load?

20.

Family compliance?

21.

Compliance by nurse?
good
moderate
poor

22.

Number of appointments made with the
patient by the nurse/nurses______

23.

Number of appointments made with the
patient by the physician/physicians

no

no
charting
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